This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Loeken, M. R. Search for Related Content PubMed PubMed Citation Articles by Loeken, M. R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Complications High Risk Pregnancy Neural Tube Defects Hazardous Substances DB GLUCOSE Social Bookmarking                         What's this?

Advances in Understanding the Molecular Causes of Diabetes-Induced Birth Defects

Section on Developmental and Stem Cell Biology, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts; mary.loeken{at}joslin.harvard.edu

Objective: To review the current understanding of the molecular causes of birth defects resulting from diabetic pregnancy, with a focus on neural tube defects.

Methods: A mouse model of diabetic pregnancy is described, in which embryo gene expression associated with neural tube defects is examined. Chemical, physiologic, or genetic manipulations are employed to elucidate critical pathways affected by increased glucose metabolism, and how abnormal gene expression disrupts neural tube closure.

Results: Increased glucose delivery to embryos, or activation of pathways that are stimulated by high glucose, such as the hexosamine biosynthetic pathway or hypoxia, increase oxidative stressin embryos, inhibit expression of Pax3, a gene that encodes a transcription factor that is required for neural tube closure, and increase neural tube defects. Conversely, blocking these pathways, or providing the antioxidants, reduced glutathione or vitamin E, suppress the adverse effects of excess glucose. Pax3 decreases steady-state levels of the p53 tumor-suppressor protein, such that when Pax3 is deficient, p53 protein increases, leading to increased neuroepithelial apoptosis prior to completion of neural tube closure. Embryos that lack both functional Pax3 protein and p53 do not display neuroepithelial apoptosis or neural tube defects.

Conclusions: Excess glucose metabolism by embryos resulting from maternal hyperglycemia disturbs a complex network of biochemical pathways, leading to oxidative stress. Oxidative stress inhibits expression of genes, such as Pax3, which control essential developmental process. Pax3 protein is required during neural tube development to suppress p53-dependent cell death and consequent abortion of neural tube closure, but is not required to control expression of genes that direct neural tube closure. Impaired embryo gene expression resulting from oxidative stress, and consequent apoptosis or disturbed organogenesis, may be a general mechanism to explain diabetic embryopathy.

Key Words: Diabetic embryopathy • diabetic pregnancy • neural tube defect • Pax3 • p53

References

• 1. White P. Pregnancy complicating diabetes. Am J Med 1949;7:609-616.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 2. White P. Pregnancy complicating diabetes, in: Joslin EP, Root HF, White P, Marble A, eds. The treatment of diabetes mellitus. Philadelphia: Lea & Febiger, 1937:633-638.
• 3. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 2002;19:322-326.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 4. Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 1995;18:1446-1451.[Abstract]
• 5. The Diabetes Control and Complications Trial Research Group: Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 1996;174:1343-1353.[Web of Science][Medline] [Order article via Infotrieve]
• 6. Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med 2000;9:35-41.[CrossRef][Medline] [Order article via Infotrieve]
• 7. Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 2000;43:79-82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 8. Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000;182:313-320.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 9. Loffredo CA, Wilson PD, Ferencz C. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 2001;64:98-106.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 10. Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart 2003;89:1217-1220.[Abstract/Free Full Text]
• 11. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001;61:85-95.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 12. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ 2004;328:915-919.[Abstract/Free Full Text]
• 13. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996;275:1093-1096.[Abstract/Free Full Text]
• 14. Werler MW, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA 1996;275:1089-1092.[Abstract/Free Full Text]
• 15. Moore LL, Singer MR, Bradlee ML, Rothman KJ, Milunsky A. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology 2000;1:689-694.
• 16. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics 2003;111:1152-1158.[Abstract/Free Full Text]
• 17. Kaufman FR. Type 2 diabetes mellitus in children and youth: A new epidemic. J Pediatr Endocrinol Metab 2002;15 Suppl 2:737-744.[Web of Science]
• 18. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-1200.[Abstract/Free Full Text]
• 19. Siman CM, Eriksson UJ. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 1997;46:1054-1061.[Abstract]
• 20. Sivan E, Reece EA, Wu Y-K, Homko CJ, Polansky M, Borenstein M. Dietary vitamin E prophylaxis and diabetic embryopathy: Morphologic and biochemical analysis. Am J Obstet Gynecol 1996;175:793-799.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 21. Viana M, Herrera E, Bonet B. Terotogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia 1996;39:1041-1046.
• 22. Wentzel P, Eriksson UJ. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes 1998;47:677-684.[Abstract]
• 23. Reece E, Homko C, Wu U, Wiznitzer A. The role of free radicals and membrane lipids in diabetes-induced congenital malformations. J Soc Gynecol Investig 1998;5:178-187.[Web of Science][Medline] [Order article via Infotrieve]
• 24. Wentzel P, Welsh N, Eriksson UJ. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes 1999;48:813-820.[Abstract]
• 25. Engstrom E, Haglund A, Eriksson UJ. Effects of maternal diabetes or in vitro hyperglycemia on uptake of palmitic and arachidonic acid by rat embryos. Pediatr Res 1991;30:150-153.[Web of Science][Medline] [Order article via Infotrieve]
• 26. Hiramatsu Y, Sekiguchi N, Hayashi M, et al. Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy. Diabetes 2002;51:2804-2810.[Abstract/Free Full Text]
• 27. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for the specific birth defects: A population-based case-control study. Pediatrics 1990;85:1-9.[Abstract/Free Full Text]
• 28. Phelan SA, Ito M, Loeken MR. Neural tube defects in embryos of diabetic mice: Role of the Pax-3 gene and apoptosis. Diabetes 1997;46:1189-1197.[Abstract]
• 29. Barr M Jr, Hanson JW, Currey K, et al. Holoprosencephaly in infants of diabetic mothers. J Pediatr 1983;102:565-568.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 30. Goulding MD, Chalepakis G, Deutsch U, Erselius JR, Gruss P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 1991;10:1135-1147.[Web of Science][Medline] [Order article via Infotrieve]
• 31. Auerbach R. Analysis of the developmental effects of a lethal mutation in the house mouse. J Exp Zool 1954;127:305-329.[CrossRef][Web of Science]
• 32. Chalepakis G, Goulding M, Read A, Strachan T, Gruss P. Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc Natl Acad Sci U S A 1994;91:3685-3689.[Abstract/Free Full Text]
• 33. Epstein DJ, Vogan KJ, Trasler DG, Gros P. A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc Natl Acad Sci U S A 1993;90:53-56.
• 34. Goulding M, Sterrer S, Fleming J, et al. Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 1993;17:355-363.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 35. Fine E, Horal M, Chang T, Fortin G, Loeken M. Hyperglycemia is responsible for altered gene expression, apoptosis, and neural tube defects associated with diabetic pregnancy. Diabetes 1999;48:2454-2462.[Abstract]
• 36. Terzic J, Saraga-Babic M. Expression pattern of PAX3 and PAX6 genes during human embryogenesis. Int J Dev Biol 1999;43:501-508.[Web of Science][Medline] [Order article via Infotrieve]
• 37. Okladnova O, Syagailo YV, Tranitz M, et al. Functional characterization of the human PAX3 gene regulatory region. Genomics 1999;57:110-119.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 38. Moore KL, Persaud TVN. The developing human—Clinically oriented embryology. Philadelphia, Saunders; 1993.
• 39. Naftolin F, Diamond MP, Pinter E, Reece EA, Sanyal MK. A hypothesis concerning the general basis of organogenetic congenital anomalies. Am J Obstet Gynecol 1987;157:1-4.[Web of Science][Medline] [Order article via Infotrieve]
• 40. Chang TI, Horal M, Jain S, Wang F, Patel R, Loeken MR. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 2003;46:538-545.[Web of Science][Medline] [Order article via Infotrieve]
• 41. Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 1985;237:408-414.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 42. Akazawa S, Unterman T, Metzger BE. Glucose metabolism in separated embryos and investing membranes during organogenesis in the rat. Metabolism 1994;43:830-835.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 43. El-Hage S, Singh SM. Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levels during in utero development in mice. Dev Genet 1990;11:149-159.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 44. Sussman I, Matschinsky FM. Diabetes affects sorbitol and myoinositol levels of neuroectodermal tissue during embryogenesis in rat. Diabetes 1988;37:974-981.[Abstract]
• 45. McClain DA. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetes Complications 2002;16:72-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 46. McClain DA, Crook ED. Hexosamines and insulin resistance. Diabetes 1996;45:1003-1009.[Abstract]
• 47. Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc. Science 2001;291:2376-2378.[Abstract/Free Full Text]
• 48. Kanji MI, Toews ML, Carper WR. A kinetic study of glucose-6-phosphate dehydrogenase. J Biol Chem 1976;251:2258-2262.[Abstract/Free Full Text]
• 49. Hunter ES, Sadler TW. Embryonic metabolism of foetal fuels in whole-embryo culture. Toxic In Vitro 1988;2:163-167.
• 50. Clough JR, Whittingham DG. Metabolism of [14]glucose by postimplantation mouse embryos in vitro. J Embryol Exp Morphol 1983;74:133-142.[Web of Science][Medline] [Order article via Infotrieve]
• 51. Sakamaki H, Akazawa S, Ishibashi M, et al. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 1999;48:1138-1144.[Abstract]
• 52. Trocino RA, Akazawa S, Ishibashi M, et al. Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 1995;44:992-998.[Abstract]
• 53. Horal M, Zhang Z, Virkamaki A, Stanton R, Loeken MR. Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: Involvement in diabetic teratogenesis. Birth Defects Res Part A Clin Mol Teratol 2004;70:519-527.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 54. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. J Biol Chem 1991;266:4706-4712.[Abstract/Free Full Text]
• 55. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994;43:1122-1129.[Abstract]
• 56. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A 1989;86:5141-5145.[Abstract/Free Full Text]
• 57. Nishikawa T, Edelstein D, Brownlee M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int 2000;58 Suppl 77:S26-s30.
• 58. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.[CrossRef][Medline] [Order article via Infotrieve]
• 59. Babazono T, Kapor-Drezgic J, Dlugosz JA, Whiteside C. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 1998;47:668-676.[Abstract]
• 60. Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000;49:1939-1945.[Abstract]
• 61. Wentzel P, Ejdesjo A, Eriksson UJ. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos. Diabetes 2003;52:1222-1228.[Abstract/Free Full Text]
• 62. Zheng L, Roeder RG, Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key cmponent. Cell 2003;114:255-266.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 63. Fischer B, Bavister BD. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil 1993;99:673-679.[Abstract/Free Full Text]
• 64. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992;80:283-285.[Web of Science][Medline] [Order article via Infotrieve]
• 65. Adelman DM, Maltepe E, Simon MC. Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev 1999;13:2478-2483.[Abstract/Free Full Text]
• 66. Li R, Chase M, Jung SK, Smith PJS, Loeken MR. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 2005;288:E591-E599.
• 67. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 1998;95:11715-11720.[Abstract/Free Full Text]
• 68. Paddenberg R, Ishaq B, Goldenberg A, et al. Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature. Am J Physiol Lung Cell Mol Physiol 2003;284:L710-L719.[Abstract/Free Full Text]
• 69. Chandel NS, McClintock DS, Feliciano CE, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing. J Biol Chem 2000;275:25130-25138.[Abstract/Free Full Text]
• 70. Chandel NS, Vander Heiden MG, Thompson CB, Schumacker PT. Redox regulation of p53 during hypoxia. Oncogene 2000;19:3840-3848.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 71. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000;275:26765-26771.[Abstract/Free Full Text]
• 72. Chern CL, Huang RF, Chen YH, Cheng JT, Liu TZ. Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells. Biomed Pharmacother 2002;55:434-442.
• 73. Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett 2000;470:20-24.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 74. Nakano E, Higgins JA, Powers HJ. Folate protects against oxidative modification of human LDL. Br J Nutr 2001;86:637-639.[Web of Science][Medline] [Order article via Infotrieve]
• 75. Parman T, Wiley MJ, Wells PG. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 1999;5:582-585.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 76. Wells PG, Winn LM. Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 1996;31:1-40.[Web of Science][Medline] [Order article via Infotrieve]
• 77. Hassoun EA, Walter AC, Alsharif NZ, Stohs SJ. Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid. Toxicology 1997;124:27-37.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 78. Bankson DD, Kestin M, Rifai N. Role of free radicals in cancer and atherosclerosis. Clin Lab Med 1993;13:463-480.[Web of Science][Medline] [Order article via Infotrieve]
• 79. Graf WD, Oleinik OE, Pippenger CE, Eder DN, Glauser TA, Shurtleff DB. Comparison of erythrocyte antioxidant enzyme activities and embryologic level of neural tube defects. Eur J Pediatr Surg 1995;5 Suppl 1:8-11.[Medline] [Order article via Infotrieve]
• 80. Bernasconi M, Remppis A, Fredericks WJ, Rauscher FJ, Schafter BW. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc Natl Acad Sci U S A 1996;93:13164-13169.[Abstract/Free Full Text]
• 81. Maulbecker CC, Gruss P. The oncogenic potential of Pax genes. EMBO J 1993;12:2361-2367.[Web of Science][Medline] [Order article via Infotrieve]
• 82. Pani L, Horal M, Loeken MR. Rescue of neutral tube defects in Pax-3-deficient embryos by p53 loss of function: Implications for Pax-3-dependent development and tumorigenesis. Genes Dev 2002;16:676-680.[Abstract/Free Full Text]
• 83. Ishii H, Jirousek MR, Koya D, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996;272:728-731.[Abstract]
• 84. Wentzel P, Wentzel CR, Gareskog MB, Eriksson UJ. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 2001;63:193-201.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 85. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.[Abstract/Free Full Text]

Journal of the Society for Gynecologic Investigation, Vol. 13, No. 1, 2-10 (2006)
DOI: 10.1016/j.jsgi.2005.09.007


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Loeken, M. R. Search for Related Content PubMed PubMed Citation Articles by Loeken, M. R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Complications High Risk Pregnancy Neural Tube Defects Hazardous Substances DB GLUCOSE Social Bookmarking                         What's this?